GHK-Cu Copper Peptide: Dosage, Uses, and What to Know. A physician-tone guide to GHK-Cu (copper peptide), covering how it works, typical topical dosage ranges, common forms, safety considerations, and what the
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper peptide found in human plasma, saliva, and urine. Levels decline with age, and interest in GHK-Cu has grown across skin, hair, and wound-healing research.
This guide explains what GHK-Cu is, how it is thought to work, typical dosage ranges discussed in the literature, and what patients should know before considering it.
GHK-Cu is a small tripeptide (glycine, histidine, lysine) bound to a single copper ion. Key characteristics include:
Published research suggests GHK-Cu may influence several biological pathways, including:
These effects are studied in cell culture, animal models, and small human trials. Larger controlled trials remain limited.
GHK-Cu appears in several formats, each with different considerations:
Only formulations produced under pharmaceutical or licensed cosmetic manufacturing standards should be considered for personal use.
Dosage varies by route and purpose. The ranges below reflect what is described in published studies and cosmetic formulations, not a personal recommendation.
| Route | Typical Concentration or Dose | Frequency | Notes | ||
|---|---|---|---|---|---|
| --- | --- | --- | --- | ||
| Topical skin serum | 0.05 to 2 percent | Once or twice daily | Most common cosmetic range | ||
| Scalp serum for hair support | 0.1 to 1 percent | Daily on dry scalp | Marketed for thinning hair | ||
| Compounded subcutaneous | 1 to 2 mg per dose | Several times weekly | Physician supervision only | ||
| Post-procedure recovery serum | 0.1 to 0.5 percent | Short 1 to 4 week course | After microneedling or laser |
Appropriate dose depends on skin sensitivity, other active ingredients in the routine, medical history, and the treating clinician's judgment.
Across available studies, GHK-Cu has been associated with:
Most trials are small, short in duration, or industry-supported. GHK-Cu is not a substitute for evidence-based medical treatment for any disease.
Topical GHK-Cu is generally well tolerated. Reported considerations include:
A patch test before starting a new GHK-Cu product is a reasonable precaution.
GHK-Cu is a naturally occurring copper peptide with a long research history in skin, hair, and wound-healing settings. Topical concentrations between 0.05 and 2 percent are most commonly described, and injectable use requires physician oversight. Anyone considering GHK-Cu should discuss suitability, dosage, and interactions with a qualified clinician.
This article is for general informational and educational purposes only and is not a substitute for personalized medical advice. Always consult a qualified healthcare professional before starting any new treatment.